Innovita Biological Technology Co., Ltd. (SHA:688253)

China · Delayed Price · Currency is CNY

34.80

+1.16 (3.45%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Diagnostic Kits / Equipment	422.03M	621.39M	478.02M	446.62M	326.91M
Diagnostic Kits / Equipment Growth	-32.08%	29.99%	7.03%	36.62%	-68.48%
Total	422.03M	621.39M	478.02M	446.62M	326.91M
Total Growth	-32.08%	29.99%	7.03%	36.62%	-68.48%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
East China	219.95M	-	-	-
Northwest China	54.08M	-	-	-
North China	96.95M	-	-	-
Central China	62.13M	-	-	-
Southwest China	91.70M	-	-	-
Northeast China	29.63M	-	-	-
South China	51.31M	-	-	-
Overseas (including Hong Kong, Macao and Taiwan)	15.63M	-	-	-
Total	621.39M	-	-	-

Source: S&P Global Market Intelligence.